Astrazenca was underperforming the markets. Recently the stock has taken support at previous pivot low and resistance turned support. Low risk entry available for high risk reward
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
